Renato Bassan

Venice, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications

Adult ALL: identify the culprits, initiate response.

Adult ALL: identify the culprits, initiate response.

Journal: Blood
Published: August 20, 2026

Allogeneic stem cell transplantation in adult Ph-like acute lymphoblastic leukemia. Results from two consecutive GIMEMA protocols.

Allogeneic stem cell transplantation in adult Ph-like acute lymphoblastic leukemia. Results from two consecutive GIMEMA protocols.

Journal: Bone marrow transplantation
Published: March 18, 2026

Shaping the future of older patients with Philadelphia-negative lymphoblastic leukemia.

Shaping the future of older patients with Philadelphia-negative lymphoblastic leukemia.

Journal: Haematologica
Published: February 19, 2026

Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint.

Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint.

Journal: Leukemia
Published: March 04, 2025

Clinical impact of tyrosine kinases related mutations in NPM1 mutated acute myeloid leukaemia: A report from the Northern Italy Leukaemia Group (NILG) multicentre randomized trial 02/06.

Clinical impact of tyrosine kinases related mutations in NPM1 mutated acute myeloid leukaemia: A report from the Northern Italy Leukaemia Group (NILG) multicentre randomized trial 02/06.

Journal: Leukemia research
Published: March 02, 2025

Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: the GIMEMA LAL2317 phase 2 study.

Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: the GIMEMA LAL2317 phase 2 study.

Journal: Blood
Published: November 08, 2024

Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemia.

Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemia.

Journal: The Lancet. Haematology
Published: June 21, 2024

Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study.

Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study.

Journal: Haematologica
Published: May 15, 2024

Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL.

Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 21, 2023

Management of ALL in adults: 2024 ELN recommendations from a European expert panel.

Management of ALL in adults: 2024 ELN recommendations from a European expert panel.

Journal: Blood
Published: December 19, 2023

A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study.

A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study.

Journal: Blood advances
Published: September 12, 2023

A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.

A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.

Journal: Annals of hematology
Published: August 04, 2023
Showing 1-12 of 81

Last Updated: 09/26/2026